Had preliminary meeting with Cempra DM. He was dumb as a stump. Told me they are hiring a primary care sales force for their new IV/Oral antibiotic. He looked me up for my antibiotic experience, but stated this was a primary care drug that will be promoted almost exclusively to family practice and internal medicine offices. he wanted to have 8 aggressive PC reps and 2 antibiotic reps as internal trainers. Went on to say that hospitals and infectious disease physicians will be avoided the first year of launch. Also said that local and regional managed care organizations will not be looking at solithromycin, so they should be able to sneak past prior auths and formulary reviews !!! He actually used the term stealth tactics. Can anybody say disgrace. How about antimicrobial stewardship, patient outcome, or multi-drug resistance. Solithromycin will be reviewed by PBM PharmDs like any other drug and held in reserve for the patients that really need it. Holy Crap... Noticed on linked in they hired a bunch of former J&J mutts and Salix folks ???
Run from Cempra with both hands and both feet. Organization in complete disarray and they have not even hit the market yet. Bunch of greasy new yorkers from J&J that still think it is 1992 without managed care restrictions. Solithro will be restricted. I agree with the first post. J&J was as sleazy as it got with Levofloxicin. The research side of Cempra really made a mistake when they let these guys in the door.
They will be now. Have no choice but to do so.... Never understood why people come to places like this with this type of leadership?!!?!
